معرفی
Thejal Srikumar, MD, is an Assistant Professor of Medicine in the Department of Medical Oncology and Hematology at Yale School of Medicine. She practices at Smilow Cancer Hospital and Yale Cancer Center in New Haven, specializing in gastrointestinal cancers, particularly in young adults and those with genetic predispositions. She is also affiliated with the Center for Gastrointestinal Cancers, the Early Onset Cancer Program, and the Smilow Cancer Genetics & Prevention Program.
- Education: MD from University of South Florida Morsani College of Medicine; Executive MPH from Yale School of Public Health (Epidemiology & Health Informatics); Residency and Fellowship in Internal Medicine and Hematology/Oncology at Yale, where she served as Chief Resident and Chief Fellow.
Her research focuses on gastrointestinal malignancies, early-onset cancers, and the intersection of cancer, obesity, and imaging biomarkers. She has published on topics including CT-based staging, visceral adiposity, and multimodal treatment for gastric cancer. Her work often involves interdisciplinary collaboration with colleagues in surgery, radiology, and public health.
Recent publications highlight her dual commitment to clinical oncology and medical education. She has led initiatives on communication skills training, pharmacology curriculum development, and longitudinal wellness programs for hematology/oncology fellows, reflecting her role as Assistant Program Director of the fellowship program.
Scientific Awards:
- No specific awards listed in the provided text.
Dr. Srikumar is actively involved in mentoring and teaching, supervising fellows in clinical and didactic settings. She contributes to curriculum development and professional development initiatives. Her work bridges clinical care, research, and education, with a strong emphasis on improving outcomes for high-risk cancer populations and enhancing training for future oncologists.
Labs and Teams: She collaborates with the Breast Medical Oncology Group and other oncology research teams at Yale, though she does not lead a standalone lab. Her work is embedded within the clinical and educational infrastructure of the Hematology/Oncology division.